- Home
- EQS vs LVTX Comparison
EQS vs LVTX Comparison
Compare EQS & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQS
- LVTX
- Stock Information
- Founded
- EQS 1991
- LVTX 2016
- Country
- EQS United States
- LVTX Netherlands
- Employees
- EQS N/A
- LVTX N/A
- Industry
- EQS Finance Companies
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- EQS Finance
- LVTX Health Care
- Exchange
- EQS Nasdaq
- LVTX Nasdaq
- Market Cap
- EQS 33.7M
- LVTX 40.0M
- IPO Year
- EQS N/A
- LVTX 2021
- Fundamental
- Price
- EQS $1.95
- LVTX $1.61
- Analyst Decision
- EQS
- LVTX Hold
- Analyst Count
- EQS 0
- LVTX 4
- Target Price
- EQS N/A
- LVTX $1.58
- AVG Volume (30 Days)
- EQS 11.9K
- LVTX 485.7K
- Earning Date
- EQS 01-01-0001
- LVTX 12-09-2025
- Dividend Yield
- EQS N/A
- LVTX N/A
- EPS Growth
- EQS N/A
- LVTX N/A
- EPS
- EQS N/A
- LVTX N/A
- Revenue
- EQS $1,355,000.00
- LVTX $4,990,000.00
- Revenue This Year
- EQS N/A
- LVTX N/A
- Revenue Next Year
- EQS N/A
- LVTX N/A
- P/E Ratio
- EQS N/A
- LVTX N/A
- Revenue Growth
- EQS 60.35
- LVTX N/A
- 52 Week Low
- EQS $0.74
- LVTX $0.85
- 52 Week High
- EQS $2.49
- LVTX $2.00
- Technical
- Relative Strength Index (RSI)
- EQS 47.70
- LVTX 54.09
- Support Level
- EQS $1.75
- LVTX $1.58
- Resistance Level
- EQS $2.01
- LVTX $1.63
- Average True Range (ATR)
- EQS 0.09
- LVTX 0.05
- MACD
- EQS 0.00
- LVTX 0.00
- Stochastic Oscillator
- EQS 58.28
- LVTX 83.42
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.